| 000 | 01726 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515182024.0 | ||
| 264 | 0 | _c20100304 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1365-2885 | ||
| 024 | 7 |
_a10.1111/j.1365-2885.2008.01036.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbu-Basha, E A | |
| 245 | 0 | 0 |
_aPharmacokinetics and bioavailability of sulfadiazine and trimethoprim following intravenous, intramuscular and oral administration in ostriches (Struthio camelus). _h[electronic resource] |
| 260 |
_bJournal of veterinary pharmacology and therapeutics _cJun 2009 |
||
| 300 |
_a258-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xveterinary |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aInjections, Intramuscular _xveterinary |
| 650 | 0 | 4 |
_aInjections, Intravenous _xveterinary |
| 650 | 0 | 4 | _aJordan |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 |
_aStruthioniformes _xmetabolism |
| 650 | 0 | 4 |
_aSulfadiazine _xadministration & dosage |
| 650 | 0 | 4 |
_aTrimethoprim _xadministration & dosage |
| 700 | 1 | _aGehring, R | |
| 700 | 1 | _aHantash, T M | |
| 700 | 1 | _aAl-Shunnaq, A F | |
| 700 | 1 | _aIdkaidek, N M | |
| 773 | 0 |
_tJournal of veterinary pharmacology and therapeutics _gvol. 32 _gno. 3 _gp. 258-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2885.2008.01036.x _zAvailable from publisher's website |
| 999 |
_c19053485 _d19053485 |
||